Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06162858
Other study ID # ONZ-2023-0416
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 15, 2023
Est. completion date September 30, 2026

Study information

Verified date November 2023
Source University Hospital, Ghent
Contact Dominiek Vandenbosch, MSc
Phone +32 9 332 16 69
Email dominiek.vandenbosch@ugent.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Taking and moving objects is essential. When this becomes difficult, it affects daily functioning. This study aims to determine movement patterns, at the level of the shoulder, during different functional movements in elderly people aged 60 years and older. Movement patterns of people without shoulder problems and patients with a reverse shoulder prosthesis will be compared. These insights can contribute to improving functional rehabilitation in patients with a reverse shoulder prosthesis (RSA).


Description:

This study aims to investigate how elderly people (60 years and older) without shoulder pain and patients with a reverse shoulder arthroplasty (60 years and older) perform functional reaching movements. Using IMUs (Inertial Measurement Units), the investigators want to look at mode of execution, relational positions of hand, elbow and shoulder in space, in relation to the trunk and each other, and any compensatory movements made by patients with a reverse shoulder arthroplasty. At the time of testing, participants will first complete a series of questionnaires. These questionnaires will provide information about the daily functioning of all participants. The participants' shoulder strength will also be measured. After applying the IMUs, the participant will first perform a maximal movement (active for participant) in 4 directions (forward and lateral lifting of arm, hand-to-neck , hand-to-back). Then the researcher will perform the same movements with the participant's arm (passive for participant). This will allow measurement of the maximum active and passive mobility of the shoulder. Next, the participant will be asked to place and take back a number of different objects (both in terms of size and weight) at predetermined heights. The participants without shoulder pain will be tested once, the participants with a reverse shoulder arthroplasty we want to test 4 times. The participants without shoulder pain will be assigned to the control group. The participants with a reverse shoulder arthroplasty we want to test 4 times to monitor not only their movement pattern, but also any changes in this pattern . The questionnaires, strength measurement and requested movements will be the same for both groups. Analysis of these movements will provide us with insights that can help improve the functional rehabilitation of patients with a reverse shoulder prosthesis. All participants with a reverse shoulder arthroplasty will be recruited at UZ, participants without shoulder pain will be recruited through different channels (these are not patients)


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date September 30, 2026
Est. primary completion date September 30, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - 60 years and older - no shoulder pain + no diagnosis of shoulder problem - primary reverse shoulder arthroplasty Exclusion Criteria: - younger than 60 years - shoulder pain at moment of testing - known shoulder problem ( incl. diagnosis)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
IMU (Inertial Measurement Devices)
Functional placing and reaching of objects of different weights on different heights

Locations

Country Name City State
Belgium Ghent University Hospital Ghent
Belgium University Ghent Ghent

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Ghent University Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Other AGE specify age of participant during procedure
Other GENDER specify age of participant during procedure
Other DOMINANCE specify hand dominance of participant during procedure
Other height specify participants height during procedure
Other weight specify participants weight during procedure
Primary IMU registration (3D kinematics upper limb) kinematic registration of performed exercises by all participants healthy control group: baseline
Primary IMU registration (3D kinematics upper limb) kinematic registration of performed exercises by all participants RSA group: 3 weeks post surgery
Primary IMU registration (3D kinematics upper limb) kinematic registration of performed exercises by all participants RSA group: 6 weeks post surgery
Primary IMU registration (3D kinematics upper limb) kinematic registration of performed exercises by all participants RSA group: 12 weeks post surgery
Primary IMU registration (3D kinematics upper limb) kinematic registration of performed exercises by all participants RSA group: 6 months post surgery
Primary IMU registration (3D kinematics upper limb) kinematic registration of performed exercises by all participants RSA group: 12 months post surgery
Secondary SPADI_DV Content: 5 questions for the subscale pain and 8 questions for the disability subscale.
Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.
Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder
during procedure
Secondary Constant- Murley Score Content: partially clinical (65 points) and partially PROM (35 points) assessed.
Scoring: The formula to calculate the total score is:" pain (0-15) + ADL (4x (0-5) = 0-20) + mobility (4 x (0-10) = 0-40)
+ strength (0 -25)". Strength will be measured with the arm elevated to 90 ° in the scapular plane using an IDOmeter.
Interpretation: 0-55 points = bad, 56-70 points = mediocre, 71-85 points = good, 86-100 points = excellent score
during procedure
Secondary EQ5D5L Content: 5 questions + EQ-5D VAS for general health. Scoring: 5-response scale (from 'no problems' to 'extreme problems') + VAS percentage between 0 (worst imaginable health state) and 100 (best imaginable health state).
Interpretation: VAS score for general health indicates how a patient perceives his general health, Other questions are descriptive for problems in mobility, self-care, usual activities, pain/ discomfort, anxiety/depression
during procedure
Secondary VAS-pain Pain is scored between 0 and 10. 0 = no pain, 10= worst possible pain during procedure
Secondary AROM active range of motion for forward flexion, abduction, hand-to-neck, hand-to-back forward flexion and abduction with extended elbow, functional internal and external rotation in standing position.
maximal pain free ROM
forward flexion and abduction with extended elbow: measured with the EasyAngle (Meloq AB Sweden)
hand-to-back and hand-to-neck test : scored as in Constant-Murley Score
during procedure
Secondary PROM passive range of motion for forward flexion and abduction
maximal pain free ROM
measured with the EasyAngle (Meloq AB Sweden)
during procedure
Secondary strength strength will be measured for forward flexion in 0° elevation and in 90° elevation with the EasyForce.
FF at 0° elevation: participants will sit on a chair without backrest, both feet on the ground. Arm in neutral rotation, hand in a fist, thumb facing upward FF at 90° elevation: participants will stand, the arm with extended elbow held at 90° elevation (FF). Hand in a fist, thumb facing upward
during procedure
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1